Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine - Clinical Trial NCTNCT05846230

Business Opportunities for NCT05846230

Connect with principal investigators, study coordinators, and key decision makers for this PHASE2 trial studying investigational therapy for Bronchiectasis.

Clinical Trial Information

Study Sponsor

Sponsor information available

Drug/Intervention

Study intervention details available

Therapeutic Area

Bronchiectasis

Study Phase

PHASE2

Study Status

ACTIVE_NOT_RECRUITING

NCT Number

NCTNCT05846230

Find Contact Information

Access exclusive contact details for:

• Principal investigators and sub-investigators
• Study coordinators and research staff
• Site directors and facility contacts
• Sponsor representatives and CRO partners
• Business development professionals
• Clinical operations managers

Clinical Trial Locations

This study has 102 locations across United States, Australia, Belgium, Bulgaria, Canada, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Latvia, Mexico, Netherlands, Poland, Portugal, Spain, Turkey, United Kingdom.

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

• Discover clinical trials before competitors
• Access exclusive contact information
• Track sponsor pipelines and opportunities
• Connect with decision makers directly
• Win more business partnerships